A normal freckle is flat, uniform in color, and stays roughly the same over time, while a cancerous lesion tends to be asymmetric, multicolored, evolving, or visually different from every other spot on your body. That distinction sounds clean on paper, but in practice the line between harmless and dangerous is blurrier than most people expect. Some melanomas look nothing like the dark, irregular mole you picture, and some perfectly normal moles look alarming. Knowing what to actually watch for, including the warning signs that standard screening checklists leave out, is what separates useful skin awareness from anxiety.
What Counts as a “Freckle” and What Carries Risk
People use “freckle” loosely to mean any small brown spot, but dermatologists distinguish between at least two types. True freckles (ephelides) are the small, flat, tan-to-brown dots that pop up in childhood, darken in summer, and fade in winter. Solar lentigines, often called age spots or sun spots, are larger, darker, and more permanent marks that accumulate with years of sun exposure. Both are driven by sunlight, but true freckles are largely genetic in origin, while solar lentigines reflect cumulative photodamage over a lifetime.1PubMed. Sun-induced freckling: ephelides and solar lentigines
Neither type is cancerous in itself. But both are markers that your skin has significant UV exposure history and that the gene variants controlling your pigmentation put you in a higher-risk category. Variants in the MC1R gene, the major gene behind freckling, raise the risk of developing freckles by as much as 11-fold when a person carries two copies. Those same variants are independently associated with melanoma and non-melanoma skin cancer, even after accounting for hair color and skin type.2PubMed. The melanocortin-1-receptor gene is the major freckle gene In other words, freckles themselves don’t turn into melanoma, but the biology that produces freckles also raises your melanoma risk. This is a crucial distinction: you’re watching your moles and any new or changing spots, not nervously monitoring each individual freckle.
The ABCDE Rule and Its Limits
The most widely taught screening tool is the ABCDE checklist. It gives you five features to look for in a pigmented spot:
- Asymmetry: one half doesn’t mirror the other.
- Border: edges are ragged, notched, or blurred rather than smooth.
- Color: multiple shades of brown, black, red, white, or blue within a single spot.
- Diameter: wider than about 6 millimeters, roughly the size of a pencil eraser.
- Evolution: any change in size, shape, color, or symptoms like itching or bleeding.
These criteria work well for the most common form, superficial spreading melanoma, which tends to grow outward across the skin for months or years before it invades deeper tissue. A study of excised skin lesions found that the features most strongly distinguishing melanoma from benign spots included irregular borders, color variegation, diameter over 6 mm, and evolution within six months.3PubMed Central. Characteristic Clinical Features of Melanoma in Patients With Excised Skin Lesions So the ABCDE rule isn’t arbitrary; it captures real statistical differences.
The problem is that plenty of dangerous melanomas don’t tick those boxes. Small melanomas can be caught early before reaching 6 mm. Some start perfectly symmetric. And an entire class of melanoma, the nodular type, grows vertically from the start rather than spreading sideways, so it may appear as a small, round, raised bump that seems symmetric and well-bordered. The ABCDE checklist was never meant to catch everything. It’s a starting framework, not a complete filter.
The Ugly Duckling Sign
One of the most practical additions to the ABCDE rule is the “ugly duckling” concept. It’s based on a straightforward observation: your moles tend to resemble each other. Most people have a personal pattern to their spots, whether they’re mostly small and round and brown, or larger and darker, or light and flat. A melanoma, by contrast, tends to stand out as the odd one, the mole that doesn’t match any of the others.
In a study testing whether non-experts could spot the ugly duckling, all five melanomas in a set of 145 pigmented lesions were identified as “different” by at least 85% of observers, while only about 2% of benign lesions triggered the same reaction.4JAMA Dermatology. The “Ugly Duckling” Sign: Agreement Between Observers That’s a striking hit rate for a method that requires no special training, just a willingness to compare spots to one another rather than evaluating each one in isolation.
Despite its usefulness, the ugly duckling sign has historically been left out of public education campaigns that focus exclusively on ABCDE. A school-based prevention pilot found that before training, only about 9% of students had heard of the ugly duckling concept, compared to near-universal awareness of the ABCDE rule. After a peer education session, recognition jumped to over 91%.5PubMed Central. SUNTEL pilot study: first school-based integration of the ugly duckling sign and a dedicated e-learning platform with peer education for melanoma prevention The takeaway is simple: when you do your skin checks, don’t just run through the ABCDE list on each individual mole. Step back and look at all your spots together. The one that doesn’t belong is the one worth showing to a dermatologist.
Nodular Melanoma Breaks the Pattern
Nodular melanoma accounts for a minority of melanoma cases but a disproportionate share of melanoma deaths, precisely because it doesn’t play by the usual visual rules. Instead of spreading outward as a flat, irregularly shaped patch, it grows upward and downward as a raised, dome-shaped bump. It can be symmetric, have smooth borders, and come in a single color. What it does do, conspicuously, is change fast.
In one study of excised nodular melanomas, every single one was elevated, firm to the touch, and had evolved in size, shape, or color within six months. Rapid growth within six weeks was present in roughly 70% of cases.3PubMed Central. Characteristic Clinical Features of Melanoma in Patients With Excised Skin Lesions Patients who later discovered they had nodular melanoma described distinct warning signals: colors described as “bluish dark” or “black,” textures that became “puffy” or felt “like a hard pimple,” and shape changes happening over just weeks rather than months. Some initially dismissed their lesion as a pimple or insect bite because it didn’t look like their mental image of a mole gone wrong.6PubMed Central. Patient-identified early clinical warning signs of nodular melanoma: a qualitative study
The practical lesson: if any spot on your skin is growing noticeably over weeks, especially if it’s elevated or firm, that warrants an appointment even if it doesn’t look like a “classic” irregular mole. Speed of change is the single most reliable red flag for nodular melanoma.
When Melanoma Doesn’t Look Dark at All
Perhaps the most dangerous visual trap is amelanotic melanoma, a variant that produces little or no pigment. Instead of appearing as a dark mole, it can show up as a pink, red, or flesh-colored bump that looks more like a pimple, a small wound, or an irritated patch of skin. This makes it extraordinarily easy to miss.
In a study comparing amelanotic (red) melanomas to pigmented ones, physicians correctly included melanoma in their initial diagnosis for 94% of pigmented lesions but only 32% of the red amelanotic ones. Among the doctors who missed the amelanotic melanomas, most were dermatologists, not generalists. The lesions were commonly mistaken for basal cell carcinoma, dermatitis, infections, or benign growths.7PubMed Central. Amelanotic Melanomas Presenting as Red Skin Lesions: A Diagnostic Challenge with Potentially Lethal Consequences If trained dermatologists miss two-thirds of these, you can imagine how easily a patient would dismiss one as a pimple that won’t heal.
The cue to watch for is persistence and growth. Normal pimples, bug bites, and minor irritations heal within a few weeks. A pink or red bump that sticks around for more than a month, especially one that’s growing or occasionally bleeds, deserves professional evaluation regardless of whether it looks anything like a mole.
Melanoma in Unexpected Places and Darker Skin Tones
Acral lentiginous melanoma (ALM) develops on the palms, soles of the feet, and under fingernails or toenails. It is not linked to UV exposure, which means it shows up in areas you probably never think to check during a skin self-exam.8PubMed. Acral and nail melanoma ALM typically starts as an irregularly pigmented flat spot or a dark streak under a nail. It’s often diagnosed late because it mimics conditions like fungal nail infections, warts, bruises, and other benign problems.9PubMed Central. A Rare Case of Acral Lentiginous Melanoma
This subtype matters enormously for people with darker skin tones. While melanoma overall is far less common in Black, Asian, and Latino populations, ALM is the most frequently diagnosed melanoma subtype in non-Caucasian groups.9PubMed Central. A Rare Case of Acral Lentiginous Melanoma Research has found that roughly 70% of melanomas in people with darker skin tones arise on the plantar surface of the foot, yet many practitioners lack proficiency in spotting malignant lesions in these patients. Mortality for Black-identified individuals with melanoma runs two to three times higher than for White-identified populations, a gap driven largely by later-stage diagnosis.10MedEdPORTAL. Melanoma: Does It Present Differently in Darker Skin Tones?
If you have darker skin, your risk of melanoma is lower in absolute terms, but the melanomas you’re most at risk for tend to develop in locations you’re unlikely to monitor and may be diagnosed late. Checking between toes, on the soles of your feet, and under your nails periodically is a simple habit that addresses the specific gap.
Spots That Look Scary but Aren’t
For every melanoma that slips through undetected, there are dozens of benign spots that cause unnecessary panic. Seborrheic keratoses, the waxy, stuck-on-looking brown growths that accumulate with age, are one of the most common culprits. They can look dark, lumpy, and irregular enough to trigger alarm, but they’re entirely harmless. Research into imaging technologies has focused specifically on telling these apart from truly concerning lesions like basal cell carcinoma and melanoma, because even experienced clinicians can occasionally struggle to distinguish deeply pigmented seborrheic keratoses from something worse.11PubMed Central. Differentiation of seborrheic keratosis from basal cell carcinoma, nevi and melanoma by RGB autofluorescence imaging
Dermatofibromas, cherry angiomas, and certain types of normal moles can also look worrying to an untrained eye. The reassuring thread is that benign lesions tend to be stable. They may look weird, but they looked weird last month too, and the month before that. A spot that has been the same size, shape, and color for years is very unlikely to be melanoma, no matter how dark or oddly shaped it is.
Self-Examination Actually Works
People sometimes wonder whether checking their own skin really makes a difference, or whether it’s just a feel-good recommendation. The evidence suggests it genuinely matters. A large Italian survey found that people who regularly performed skin self-examinations had about a 35% lower odds of being diagnosed with a thick melanoma (over 1 mm) compared to those who didn’t.12PubMed. Dermatologist detection and skin self-examination are associated with thinner melanomas Thinner at diagnosis translates directly to better survival odds, because melanoma thickness is the strongest single predictor of outcome.
Separate research has found that patients’ self-assessment of which pigmented lesions are concerning lines up reasonably well with what dermatologists would flag.13PubMed. Skin self-examination for concerning pigmented lesions appears to be consistent with dermatologist examination You don’t need to be an expert to sense that something has changed or looks off. What you do need is consistency: checking your whole body periodically, including your back (use a mirror or a partner), scalp, soles of feet, and between your toes. Most people skip those areas entirely.
That said, professional screening adds something self-examination can’t. The same Italian study found that melanoma detection by a dermatologist, even incidentally during a visit for a different issue, was independently associated with thinner tumors at diagnosis.12PubMed. Dermatologist detection and skin self-examination are associated with thinner melanomas Annual skin checks with a dermatologist are especially valuable if you have a high mole count, a personal or family history of melanoma, or a fair-skinned, freckle-prone phenotype.
What Happens When a Spot Gets Biopsied
If a doctor thinks a lesion looks suspicious, the next step is a biopsy, not a diagnosis by eye alone. No one, regardless of experience, can confirm melanoma just by looking at it. The tissue sample goes to a pathologist, who examines it under a microscope and reports on a specific set of parameters: whether the lesion is melanoma or benign, its thickness (measured as Breslow thickness in millimeters), whether it’s ulcerated, its mitotic rate (how fast the cells are dividing), whether there’s any lymphovascular invasion, and whether surgical margins are clear.14Austin Journal of Dermatology. The Histopathological Diagnosis and Reporting of Melanoma: A New Look at an Old Challenge Each of these details shapes the treatment plan and prognosis.
Modern surveillance of high-risk patients has increasingly adopted total body photography combined with digital dermoscopy, where moles are photographed and tracked over time so that even subtle changes become visible by comparison. A prospective study of this approach found that nearly half of the melanomas caught through surveillance were detected through changes visible on body photography alone, without needing dermoscopy to flag them.15European Journal of Cancer. Clinical outcomes of 3D-total body photography and digital dermoscopy for surveillance of high-risk melanoma patients This type of monitoring is typically reserved for people with many atypical moles or a strong family history, but the principle applies at home too: photographing your moles yearly gives you a reference point to spot gradual changes your memory alone would miss.
AI Skin-Check Apps and Their Real Accuracy
Smartphone apps that claim to assess your moles using artificial intelligence have exploded in popularity. The technology behind them is real: deep-learning models trained on thousands of dermoscopic images can, under controlled conditions, classify skin lesions with high accuracy. A systematic review of AI models for skin cancer detection in Asian populations found that nearly half of the studies reported accuracy over 90%.16PubMed Central. The Use of Artificial Intelligence for Skin Cancer Detection in Asia—A Systematic Review In one primary care implementation, an AI model using dermoscopy images achieved about 89% accuracy in classifying melanoma, with sensitivity above 90%.17PubMed Central. Implementation of artificial intelligence algorithms for melanoma screening in a primary care setting
Those numbers sound impressive, but real-world performance is messier. A systematic review and meta-analysis of prospective studies, meaning studies where the AI was tested on lesions before the diagnosis was known rather than on curated image sets, found pooled sensitivity of about 81% and specificity around 76%.18JAMA Dermatology. Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis That means roughly one in five melanomas could be missed, and about one in four benign lesions might be flagged as suspicious. For context, that’s useful as a nudge to see a doctor but nowhere near reliable enough to replace one. If an app tells you a spot looks fine, that doesn’t let you off the hook for a professional evaluation if the spot is changing.
The more valuable role for AI may turn out to be triaging rather than diagnosing. An app that says “this needs a dermatologist’s eye” could motivate someone to book an appointment they’d otherwise put off. The danger comes when people treat the app’s reassurance as a clean bill of health and stop monitoring a spot that’s evolving.
The One Under Your Toenail
Subungual melanoma, the type that grows under a fingernail or toenail, deserves special mention because it is so regularly misidentified. It typically begins as a dark longitudinal streak in the nail, a brown or black line running from the cuticle to the tip. Many people assume it’s a bruise or a fungal infection. Acral lentiginous melanoma can clinically mimic onychomycosis, subungual hematomas, and even warts, which is part of why diagnosis is frequently delayed.9PubMed Central. A Rare Case of Acral Lentiginous Melanoma
A few features help separate a harmless nail streak from something concerning. A bruise under the nail grows out with the nail and eventually disappears over weeks to months. A melanoma streak stays put or widens. Pigment that bleeds onto the skin surrounding the nail fold, sometimes called Hutchinson’s sign, is a particularly worrying indicator. And while single-digit dark nail streaks are very common in people with darker skin and usually entirely benign, any new streak in a person with lighter skin, any streak that is widening, or any streak accompanied by nail dystrophy (the nail cracking, splitting, or lifting) warrants a dermatology visit.19PubMed. Understanding acral lentiginous melanoma: from the clinic to guidelines Most often the answer will be reassuring. But the cost of missing subungual melanoma is high enough that erring on the side of getting it checked is well worth the appointment.